Skip to main content
Premium Trial:

Request an Annual Quote

Just to Know

At the time that the Human Genome Project was going on, many people knew that it was being oversold, writes Jonathan Eisen at The Tree of Life. (He adds that he wished he had a blog at the time so he could have given it his "Overselling Genomics Award.") And so, he's not surprised at the current "backlash" against the project — he rounds up some recent stories that say that the project hasn't lived up to its expectations. "The problem here is that the human genome project should never have been sold as a means to a series of practical ends. It should have been sold as a massive basic science project, much like going to the moon or building a giant linear accelerator," Eisen writes. "That is, the human genome project was, and still really is, about knowledge. It is about knowing ourselves."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.